Isakson and Columbus receive Ivy Foundation Grant

The Ivy Foundation Biomedical Innovation Grants awarded Isakson and Columbus $80,000 in funding to develop novel anti-hypertensive therapeutics that target the hemoglobin alpha and eNOS interaction that they discovered.
Read more about other awards at UVA Today